UBS O'Connor »

Context Therapeutics shares owned by UBS O'Connor

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by UBS O'Connor from 13F filings

Historical chart of UBS O'Connor investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by UBS O'Connor

Quarter filed Position value Share count Share price at filing
2024-03-31 $409k 297k 1.38
2023-09-30 $447k 296k 1.51
2023-06-30 $105k 66k 1.60